These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of guanadrel and guanethidine. Hansson L; Pascual A; Julius S Clin Pharmacol Ther; 1973; 14(2):204-8. PubMed ID: 4571980 [No Abstract] [Full Text] [Related]
3. Comparison of guanadrel and guanethidine efficacy and side effects. Malinow SH Clin Ther; 1983; 5(3):284-9. PubMed ID: 6850722 [TBL] [Abstract][Full Text] [Related]
4. Guancydine: a new antihypertensive agent. Use with quinethazone and guanethidine or propranolol. Clark DW; Goldberg LI Ann Intern Med; 1972 Apr; 76(4):579-85. PubMed ID: 4565483 [No Abstract] [Full Text] [Related]
5. Comparison of the antihypertensive effectiveness of guanadrel and guanethidine. Chrysant SG; Frohlich ED Curr Ther Res Clin Exp; 1976 Mar; 19(3):379-85. PubMed ID: 817868 [No Abstract] [Full Text] [Related]
6. Guanadrel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension. Finnerty FA; Brogden RN Drugs; 1985 Jul; 30(1):22-31. PubMed ID: 3896742 [TBL] [Abstract][Full Text] [Related]
7. Guanethidine and bethanidine in the management of hypertension. Moser M Am Heart J; 1969 Mar; 77(3):423-6. PubMed ID: 4387977 [No Abstract] [Full Text] [Related]
8. Comparative study of two antihypertensive agents: guanfacine and guanethidine. Szám I; Kállay K Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786 [TBL] [Abstract][Full Text] [Related]
9. Guanadrel sulfate: a postganglionic sympathetic inhibitor for the treatment of mild to moderate hypertension. Palmer JD; Nugent CA Pharmacotherapy; 1983; 3(4):220-9. PubMed ID: 6351026 [No Abstract] [Full Text] [Related]
10. Letter: Debrisoquine, guanethidine, and bethanidine in hypertension. Talbot S; O'Malley BC; Bing RH Br Med J; 1975 May; 2(5965):278. PubMed ID: 1131592 [No Abstract] [Full Text] [Related]
11. Guanadrel. A new antihypertensive drug. Dunn MI; Dunlap JL JAMA; 1981 Apr; 245(16):1639-42. PubMed ID: 7206175 [TBL] [Abstract][Full Text] [Related]
12. Study of a new antihypertensive (guanabenz). McMahon FG; Cole PA; Boyles PW; Vanov SK Curr Ther Res Clin Exp; 1974 May; 16(5):389-97. PubMed ID: 4209126 [No Abstract] [Full Text] [Related]
13. [A controlled blind study of 4 antihypertensive agents (methyldopa and 3 sympatholytic agents)]. Vejlsgaard V; Christensen M; Clausen E Ugeskr Laeger; 1967 May; 129(19):635-8. PubMed ID: 4877293 [No Abstract] [Full Text] [Related]
14. A comparative clinical trial of guanoxan and guanethidine in essential hypertension. Ruedy J; Davies RO Clin Pharmacol Ther; 1967; 8(1):38-47. PubMed ID: 5334083 [No Abstract] [Full Text] [Related]
15. Medical management of primary hypertension. 3. Page LB; Sidd JJ N Engl J Med; 1972 Nov; 287(21):1074-81. PubMed ID: 4404062 [No Abstract] [Full Text] [Related]
16. [Double-blind controlled study of the therapeutic effectiveness and tolerance of the guabenxan-bemetizid combination as compared with guanethidine-hydrochlorothiazide in arterial hypertension in the aged]. Silvestrini C; Maini C; Marchesi M; Mueller G G Clin Med; 1982 Apr; 63(4):270-8. PubMed ID: 6751915 [No Abstract] [Full Text] [Related]
18. Guanadrel (Hylorel)--a new antihypertensive drug. Med Lett Drugs Ther; 1983 Oct; 25(646):95-6. PubMed ID: 6621504 [No Abstract] [Full Text] [Related]
19. Short term effectiveness and hemodynamic actions of guanadrel, a new sympatholytic drug. Pascual AV; Julius S Curr Ther Res Clin Exp; 1972 Jul; 14(7):333-42. PubMed ID: 4625513 [No Abstract] [Full Text] [Related]
20. Long-term treatment of hypertension with guanfacine alone and in combination therapy. Seedat YK Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):65S-66S. PubMed ID: 6994781 [No Abstract] [Full Text] [Related] [Next] [New Search]